Director/PDMR Shareholding
Source: RNS
28 May 2019
RECKITT BENCKISER GROUP PLC
DIRECTOR/PDMR SHAREHOLDINGS
Notification of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
The Company received notification on 24 May 2019 that on 23 May 2019 the following Directors/PDMRs acquired shares through participation in the Company's Dividend Reinvestment Plan:
|
Name |
Director / PDMR |
Number of Shares Acquired |
Price per Share |
|
Mary Harris |
Director |
33 |
£63.8794 |
|
Rob De Groot |
PDMR |
1,016 |
£63.8794 |
|
Aditya Sehgal |
PDMR |
583 |
£63.8794 |
The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
Mary Harris |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
Non-Executive Director |
||||||
|
b) |
Initial notification/ |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||||
|
e) |
Date of the transaction |
2019-05-23 |
||||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
Rob De Groot |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
President, Hygiene Home |
||||||
|
b) |
Initial notification/ |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||||
|
e) |
Date of the transaction |
2019-05-23 |
||||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
|
a) |
Name |
Aditya Sehgal |
||||||
|
2 |
Reason for the notification |
|||||||
|
a) |
Position/status |
Chief Operating Officer, Health |
||||||
|
b) |
Initial notification/ |
Initial notification |
||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name |
Reckitt Benckiser Group plc |
||||||
|
b) |
LEI |
5493003JFSMOJG48V108 |
||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 |
||||||
|
b) |
Nature of the transaction |
Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan |
||||||
|
c) |
Price(s) and volume(s) |
|
||||||
|
d) |
Aggregated information - Aggregated volume - Price |
|
||||||
|
e) |
Date of the transaction |
2019-05-23 |
||||||
|
f) |
Place of the transaction |
London Stock Exchange, Main Market - XLON |
||||||
Contact:
Christine Logan
Deputy Company Secretary
Reckitt Benckiser Group plc
01753 217800
103-105 Bath Road, Slough SL1 3UH
Registered in England and Wales, No. 6270876
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
About RB
RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.
Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.
For more information visit www.rb.com
*RB is the trading name of the Reckitt Benckiser group of companies
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
